Dynavax to Present at the H.C. Wainwright 25th Annual Global Investment Conference
- Wall St rises as dovish Fed comments bolster rate cut hopes
- Barclays raises 2024 S&P 500 price target but warns stocks are 'moving too far, too fast'
- Stocks rise as dollar falls, gold rallies on Fed commentary
- Micron (MU) raises forecast on improved supply/demand balance and pricing
- There is a 'significant shift in sentiment' on Boeing stock says RBC and upgrades to buy
The fireside chat will be webcast and may be accessed through the "Events & Presentations" page on the "Investors" section of the Company's website at https://investors.dynavax.com/events-presentations.
Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B® vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/dynavax-to-present-at-the-hc-wainwright-25th-annual-global-investment-conference-301919772.html
SOURCE Dynavax Technologies
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- How UHNW Families are Navigating Oxbridge's Private School Penalty with Private Tutoring
- Enter the Nationwide Jingle Challenge High School Music Contest
- Fosun Pharma USA Announces Abstract to be Presented at IASLC 2023 North America Conference on Lung Cancer (NACLC)
Create E-mail Alert Related CategoriesPRNewswire, Press Releases
Related EntitiesTwitter, H.C. Wainwright
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!